Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH)

K-Number: K910739 · 1991-03-21

ApplicantV-Tech, Inc.
Decision Date1991-03-21
Product CodeDKZ
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH) is the device name listed in this FDA 510(k) record. The listed applicant is V-Tech, Inc.. It received FDA 510(k) clearance on 1991-03-21 under 510(k) number K910739. The device is classified under product code DKZ. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH)?

TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH) is a medical device that received FDA 510(k) clearance on 1991-03-21. The listed applicant is V-Tech, Inc.. The 510(k) number is K910739.

When did TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH) receive FDA 510(k) clearance?

TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH) received FDA 510(k) clearance on 1991-03-21, under 510(k) number K910739.

Who is the listed applicant for TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH)?

The FDA 510(k) record lists V-Tech, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH)?

The FDA product code for TARGET AMPHETAMINE/METHAMPHETAMINE-R (READER METH) is DKZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing V-Tech, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K914303TARGET(TM)-HOGK910893TARGET(TM) CANNABINOIDS-R TESTK910892TARGET(TM) CANNABINOIDS-V TESTK910738TARGET AMPHETAMINE/METHAMPHETAMINE-V (VISUAL METH)K910123TARGET COCAINE METABOLITE-VK910122TARGET COCAINE METABOLITE-R

View all 22 devices →

Related Devices (Code: DKZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K240670DRI Ecstasy Plus AssayMicrogenics CorporationK233019AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest Multi-Drug Rapid Test Panel RxHangzhou AllTest Biotech Co., Ltd.K231137Xenta Drug Screen Cup, Xenta Drug Screen DipcardXenta Biomedical Science Co., Ltd.K200363Quidel Triage® TOX Drug Screen, 94600Quidel Cardiovascular, Inc.K191099Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test PanelAtlas MedicalK182719Quidel Triage TOX Drug Screen, 94600; Quidel Triage® MeterProQuidel Cardiovascular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑